Evoke Pharma Operating Income 2012-2024 | EVOK
Evoke Pharma operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Evoke Pharma Annual Operating Income (Millions of US $) |
2023 |
$-7 |
2022 |
$-8 |
2021 |
$-8 |
2020 |
$-13 |
2019 |
$-7 |
2018 |
$-8 |
2017 |
$-11 |
2016 |
$-11 |
2015 |
$-12 |
2014 |
$-13 |
2013 |
$-3 |
2012 |
$-2 |
2011 |
$-2 |
Evoke Pharma Quarterly Operating Income (Millions of US $) |
2024-09-30 |
$-1 |
2024-06-30 |
$-1 |
2024-03-31 |
$-2 |
2023-12-31 |
$-2 |
2023-09-30 |
$-2 |
2023-06-30 |
$-2 |
2023-03-31 |
$-2 |
2022-12-31 |
$-2 |
2022-09-30 |
$-2 |
2022-06-30 |
$-2 |
2022-03-31 |
$-2 |
2021-12-31 |
$-2 |
2021-09-30 |
$-2 |
2021-06-30 |
$-2 |
2021-03-31 |
$-3 |
2020-12-31 |
$-2 |
2020-09-30 |
$-2 |
2020-06-30 |
$-7 |
2020-03-31 |
$-2 |
2019-12-31 |
$-1 |
2019-09-30 |
$-2 |
2019-06-30 |
$-2 |
2019-03-31 |
$-2 |
2018-12-31 |
$-2 |
2018-09-30 |
$-2 |
2018-06-30 |
$-2 |
2018-03-31 |
$-2 |
2017-12-31 |
$-3 |
2017-09-30 |
$-4 |
2017-06-30 |
$-3 |
2017-03-31 |
$-2 |
2016-12-31 |
$-2 |
2016-09-30 |
$-2 |
2016-06-30 |
$-3 |
2016-03-31 |
$-3 |
2015-12-31 |
$-3 |
2015-09-30 |
$-3 |
2015-06-30 |
$-3 |
2015-03-31 |
$-3 |
2014-12-31 |
$-3 |
2014-09-30 |
$-4 |
2014-06-30 |
$-3 |
2014-03-31 |
$-3 |
2013-12-31 |
$-2 |
2013-09-30 |
$-0 |
2013-06-30 |
$-0 |
2013-03-31 |
$-0 |
2012-12-31 |
|
2012-09-30 |
$-0 |
2012-06-30 |
|
2011-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|